Venclexta
News/ News/ Sales and Marketing
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
Richard Staines
AbbVie, acute myeloid leukaemia, AML, Roche, Venclexta
0 Comment
New combination trial firms up Venclexta’s prospects in AML
Phil Taylor
AbbVie, acute myeloid leukaemia, Oncology, Roche, Venclexta
0 Comment
News/ News/ Oncology/ Top stories
AbbVie/Roche’s Venclexta fails in confirmatory AML trial
Richard Staines
AbbVie, acute myeloid leukaemia, cancer, Roche, Venclexta
0 Comment
Roche and AbbVie’s Venclexta approved in CLL
George Underwood
AbbVie, CLL, Genentech, leukaemia, Roche, Venclexta, venetoclax
0 Comment
AbbVie, Roche eye first-line use of Venclexta in leukaemia
Phil Taylor
AbbVie, leukaemia, R&D, Roche, Venclexta
0 Comment
Clinical/ News/ Sales and Marketing
AbbVie/Roche’s Venclexta produces complete remission in 10% of hard-to-treat CLL patients
Richard Staines
AbbVie, CLL, Oncology, Roche, Venclexta
0 Comment